Daniel Sansone - Ingevity Corp Independent Director
| NGVT Stock | USD 41.61 1.79 4.12% |
Director
Mr. Daniel F. Sansone is Independent Director of the Company. Mr. Sansone has served as a member of the Board of Directors, a member of the Audit Committee and chair of the Compensation Committee of AdvanSix Inc. since September 2016. He also served as Executive Vice President of Strategy at Vulcan Materials Company from January 2014 to December 2014. Vulcan, an SP 500 company, is the largest U.S. producer of aggregatesbased construction materials, including asphalt and readymixed concrete. He served as Executive Vice President and CFO at Vulcan from 2010 to 2014. Mr. Sansone had previously served at Vulcan as Senior Vice President and CFO and President of Vulcans Southern and Gulf Coast Division. Mr. Sansone also serves on various nonprofit boards. since 2016.
| Age | 68 |
| Tenure | 8 years |
| Address | 4920 O'Hear Avenue, North Charleston, SC, United States, 29405 |
| Phone | 843 740 2300 |
| Web | https://www.ingevity.com |
Daniel Sansone Latest Insider Activity
Tracking and analyzing the buying and selling activities of Daniel Sansone against Ingevity Corp stock is an integral part of due diligence when investing in Ingevity Corp. Daniel Sansone insider activity provides valuable insight into whether Ingevity Corp is net buyers or sellers over its current business cycle. Note, Ingevity Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ingevity Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Daniel Sansone over three months ago Acquisition by Daniel Sansone of 4393 shares of AdvanSix subject to Rule 16b-3 | ||
Daniel Sansone over a year ago AdvanSix exotic insider transaction detected | ||
Daniel Sansone over a year ago Acquisition by Daniel Sansone of 2975 shares of AdvanSix subject to Rule 16b-3 |
Ingevity Corp Management Efficiency
The company has return on total asset (ROA) of 0.0585 % which means that it generated a profit of $0.0585 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2081) %, meaning that it created substantial loss on money invested by shareholders. Ingevity Corp's management efficiency ratios could be used to measure how well Ingevity Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.24 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0). Change To Liabilities is likely to gain to about 51.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 219 M in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Cynthia Arnold | Cabot | 62 | |
| Frank Wilson | Cabot | 62 | |
| Michael Hanley | LyondellBasell Industries NV | 54 | |
| Mark McCollum | Westlake Chemical | 62 | |
| Douglas Grosso | Cabot | 59 | |
| Juan Enriquez | Cabot | 61 | |
| HingYuen Ho | Air Products and | 61 | |
| Chadwick Deaton | Air Products and | 68 | |
| Edward Monser | Air Products and | 70 | |
| Michael Graff | Westlake Chemical | 66 | |
| Claire Farley | LyondellBasell Industries NV | 61 | |
| David Chao | Westlake Chemical | 44 | |
| Terrence Curtin | Dupont De Nemours | 52 | |
| Dorothy Jenkins | Westlake Chemical | 75 | |
| Michael Morrow | Cabot | 65 | |
| HansDietrich Winkhaus | Orion Engineered Carbons | 82 | |
| Jeffrey Sheets | Westlake Chemical | 63 | |
| Isabella Goren | LyondellBasell Industries NV | 59 | |
| Christine Yan | Cabot | 55 | |
| Paul Huck | Orion Engineered Carbons | 70 | |
| John Chao | Westlake Chemical | 44 | |
Management Performance
| Return On Equity | -1.21 | ||||
| Return On Asset | 0.0585 |
Ingevity Corp Leadership Team
Elected by the shareholders, the Ingevity Corp's board of directors comprises two types of representatives: Ingevity Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ingevity. The board's role is to monitor Ingevity Corp's management team and ensure that shareholders' interests are well served. Ingevity Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ingevity Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| J Fitzpatrick, Independent Director | ||
| Stacy Cozad, Executive Vice President General Counsel, Company Secretary | ||
| Stuart Woodcock, Executive Materials | ||
| Daniel Sansone, Independent Director | ||
| John Nypaver, VP Relations | ||
| Christine Stunyo, Senior Officer | ||
| Jean Blackwell, Independent Chairman of the Board | ||
| Ryan Fisher, Vice President, Deputy General Counsel | ||
| Karen Narwold, Independent Director | ||
| Rich White, Senior Vice President - Performance Chemicals, and President Industrial Specialties and Pavement Technologies | ||
| Phillip Platt, Co Officer | ||
| John Fortson, President, Chief Executive Officer, Interim Chief Financial Officer, Treasurer, Director | ||
| Mary Hall, Chief Financial Officer, Executive Vice President, Treasurer | ||
| Caroline Monahan, Director Communications | ||
| Frederick Lynch, Lead Independent Director | ||
| Luis FernandezMoreno, Independent Director | ||
| Richard White, Senior Chemicals | ||
| Michael Smith, Executive Vice President and President Performance Chemicals, Strategy and Business Development | ||
| Diane Gulyas, Independent Director | ||
| Daniel Gallagher, VP Relations | ||
| Erik Ripple, VP Officer | ||
| Steven Hulme, Senior Technologies | ||
| S Woodcock, Executive Vice President and President - Performance Materials | ||
| Steve Hulme, Senior Vice President - Performance Chemicals, and President Engineered Polymers |
Ingevity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ingevity Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.21 | ||||
| Return On Asset | 0.0585 | ||||
| Profit Margin | (0.38) % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 3.05 B | ||||
| Shares Outstanding | 36.35 M | ||||
| Shares Owned By Insiders | 0.88 % | ||||
| Shares Owned By Institutions | 99.12 % | ||||
| Number Of Shares Shorted | 1.06 M | ||||
| Price To Earning | 16.90 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ingevity Stock Analysis
When running Ingevity Corp's price analysis, check to measure Ingevity Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ingevity Corp is operating at the current time. Most of Ingevity Corp's value examination focuses on studying past and present price action to predict the probability of Ingevity Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ingevity Corp's price. Additionally, you may evaluate how the addition of Ingevity Corp to your portfolios can decrease your overall portfolio volatility.